Marcus A Horwitz

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 15

Top Venues

mBio

Communications biology

Microbiology spectrum

NPJ vaccines

University of California Los Angeles

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of California Los Angeles

United States

Distinguished Professor of Medicine and Microbiology, Immunology & Molecular Genetics :: School of Medicine

University of California Los Angeles

United States

Professor of Medicine and Microbiology, Immunology & Molecular Genetics :: School of Medicine

University of California Los Angeles

United States

Chief, Division of Infectious Diseases :: Medicine

Rockefeller University

United States

Assistant Professor and Associate Physician :: Labortory of Cellular Physiology & Immunology

Rockefeller University

United States

Postdoctoral fellow :: Laboratory of Cellular Physiology & Immunology

Albert Einstein College of Medicine

United States

Fellow in Infectious Diseases :: Internal Medicine

Centers for Disease Control and Prevention

United States

Epidemic Intelligence Service Officer :: Epidemic Intelligence Service

Albert Einstein College of Medicine

United States

Intern and Resident :: INternal Medicine

Publications

Michael V Tullius, Richard A Bowen, Peter S Back, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice. mBio (2024)
Michael V Tullius, Richard A Bowen, Peter S Back, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice. mBio 15 (4) (2024)
Michael V Tullius, Richard A Bowen, Peter S Back, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice. mBio 15 (4) (2024)
Michael V Tullius, Richard A Bowen, Peter S Back, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice. mBio 15 (4) (2024)
Michael V Tullius, Richard A Bowen, Peter S Back, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
LVS Δ capB -vectored multiantigenic melioidosis vaccines protect against lethal respiratory Burkholderia pseudomallei challenge in highly sensitive BALB/c mice. mBio 15 (4) (2024)
Kevin D Mlynek, Curtis R Cline, Sergei S Biryukov, Ronald G Toothman, Beth A Bachert, Christopher P Klimko, Jennifer L Shoe, Melissa Hunter, Zander M Hedrick, Jennifer L Dankmeyer, Sherry Mou, David P Fetterer, Ju Qiu, Eric D Lee, Christopher K Cote, Qingmei Jia, Marcus A Horwitz, Joel A Bozue
The rLVS Δ capB / iglABC vaccine provides potent protection in Fischer rats against inhalational tularemia caused by various virulent Francisella tularensis strains. Human vaccines & immunotherapeutics 19 (3) (2023)
Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M Maison, Airn Hartwig, Saša Masleša-Galić, Richard A Bowen, Marcus A Horwitz
Oral Administration of Universal Bacterium-Vectored Nucleocapsid-Expressing COVID-19 Vaccine is Efficacious in Hamsters. Microbiology spectrum (2023)
Qingmei Jia, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
Listeria -Vectored Multiantigenic Tuberculosis Vaccine Enhances Protective Immunity against Aerosol Challenge with Virulent Mycobacterium tuberculosis in BCG-Immunized C57BL/6 and BALB/c Mice. mBio 13 (3) (2022)
Qingmei Jia, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge. Communications biology 5 (1) (2022)
Qingmei Jia, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge. Communications biology 5 (1) (2022)
Qingmei Jia, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge. Communications biology 5 (1) (2022)
Qingmei Jia, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz
Listeria-vectored multi-antigenic tuberculosis vaccine protects C57BL/6 and BALB/c mice and guinea pigs against Mycobacterium tuberculosis challenge. Communications biology 5 (1) (2022)
Xiaoyu Liu, Daniel L Clemens, Bai-Yu Lee, Xue Yang, Z Hong Zhou, Marcus A Horwitz
Atomic Structure of IglD Demonstrates Its Role as a Component of the Baseplate Complex of the Francisella Type VI Secretion System. mBio 13 (5) (2022)
Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel M Maison, Saša Masleša-Galić, Edward A Hoover, Richard A Bowen, Marcus A Horwitz
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19-like disease in hamsters. NPJ vaccines 6 (1) (2021)
Qingmei Jia, Helle Bielefeldt-Ohmann, Rachel Maison, Saša Masleša-Galić, Richard A Bowen, Marcus A Horwitz
Replicating bacterium-vectored vaccine expressing SARS-CoV-2 Membrane and Nucleocapsid proteins protects against severe COVID-19 disease in hamsters. bioRxiv : the preprint server for biology (2020)

Marcus A Horwitz.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marcus A Horwitz